FPCP
BMY icon

Fort Point Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History

Fort Point Capital Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$400K Buy
6,602
+207
+3% +$12.1K 0.05% 156
2025
Q4 		$366K Buy
6,395
+321
+5% +$15.4K 0.04% 175
2025
Q3 		$274K Sell
6,074
-911
-13% -$42.5K 0.03% 190
2025
Q2 		$323K Sell
6,985
-566
-7% -$27.8K 0.02% 272
2025
Q1 		$461K Sell
7,551
-563
-7% -$32.8K 0.05% 214
2024
Q4 		$459K Buy
+8,114
New +$453K 0.05% 216
2024
Q1 		– Sell
-5,881
Closed -$302K – 325
2023
Q4 		$302K Sell
5,881
-1,078
-15% -$56.6K 0.04% 237
2023
Q3 		$404K Sell
6,959
-555
-7% -$34K 0.06% 169
2023
Q2 		$481K Buy
7,514
+1,043
+16% +$69.9K 0.07% 158
2023
Q1 		$449K Buy
6,471
+119
+2% +$8.39K 0.07% 170
2022
Q4 		$457K Buy
6,352
+9
+0.1% +$679 0.07% 159
2022
Q3 		$451K Buy
6,343
+178
+3% +$12.9K 0.08% 161
2022
Q2 		$475K Buy
6,165
+28
+0.5% +$2.13K 0.08% 164
2022
Q1 		$448K Buy
6,137
+15
+0.2% +$1.01K 0.06% 186
2021
Q4 		$382K Buy
+6,122
New +$359K 0.05% 201
2017
Q2 		– Sell
-4,986
Closed -$271K – 100
2017
Q1 		$271K Sell
4,986
-100
-2% -$5.49K 0.14% 83
2016
Q4 		$254K Buy
5,086
+400
+9% +$21.9K 0.14% 80
2016
Q3 		$253K Buy
+4,686
New +$301K 0.11% 110

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fort Point Capital Partners's BMY Position: Q1 2026 in Review

Fort Point Capital Partners increased its Bristol-Myers Squibb (BMY) stake by 3.2% in Q1 2026, buying an estimated $12.1K and bringing the position to 6,602 shares worth $400K. The position accounts for 0.05% of the portfolio, ranked #156.

Fort Point Capital Partners first reported a position in BMY in Q3 2016 and has held it in 18 quarters since. The position peaked at $481K in Q2 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Fort Point Capital Partners held 6,602 shares of Bristol-Myers Squibb worth $400K as of Q1 2026.
  • Fort Point Capital Partners bought 207 Bristol-Myers Squibb shares in Q1 2026, an estimated $12.1K.
  • Bristol-Myers Squibb made up 0.05% of Fort Point Capital Partners's portfolio in Q1 2026, its #156 holding.
  • Fort Point Capital Partners first reported a position in Bristol-Myers Squibb in Q3 2016 and has held it in 18 quarters since.
  • Fort Point Capital Partners's Bristol-Myers Squibb position peaked at $481K in Q2 2023.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Fort Point Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.